Kaya Holdings, Inc.

Equities

KAYS

US4865672095

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 15:39:32 2024-06-26 EDT			5-day change	1st Jan Change
0.0455 ^USD	-5.30%		+7.06%	+8.08%

05-16	Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-16	Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

February 21, 2023 at 06:03 am

Item 8.01 Other Information.

On February 15, 2023, KAYS issued a press release announcing that its Fifth Dimension Therapeutics™ subsidiary ("FDT") had reached an agreement in principle with Florida-based Total Holistic Center™ to assist FDT with the development of its ketamine treatment model as a first step in the launch of its planned Fifth Dimension Therapeutics Mind Care Clinics and Telehealth Services.

A copy of the press release is filed with this report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.






(d)    Exhibits



Exhibit No                  Description

99.1           Press Release dated February 15, 2023

Latest news about Kaya Holdings, Inc.

Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-16	CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Kaya Holdings, Inc. Secures Site for the Sacred Mushroom(TM) Planned Psilocybin Treatment Center	23-09-28	CI
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-04-26	CI
Kaya Holdings, Inc. Launches Fifth Dimension Therapeutics to Seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market	23-01-25	CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-19	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt	22-04-17	CI
Kaya Holdings, Inc. Announces Management Changes	21-12-29	CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Kaya Holdings, Inc. announced that it expects to receive $4 million in funding	20-09-01	CI
Kaya Holdings, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2020	20-08-17	CI
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-28	CI
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-13	CI
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-19	CI
GLOBAL MARKETS LIVE: Xerox, T-Mobile, Sprint, IBM…	19-11-06

Chart Kaya Holdings, Inc.

Duration

Period

More charts

Company Profile

Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
KAYA HOLDINGS, INC.	+8.08%	1.01M
AYR WELLNESS INC.	+26.75%	254M
ASCEND WELLNESS HOLDINGS, INC.	-2.06%	203M
ORGANIGRAM HOLDINGS INC.	+20.93%	158M
JUSHI HOLDINGS INC.	+42.46%	129M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
BAKHU HOLDINGS, CORP.	+300.00%	121M
INTERCURE LTD.	+72.53%	99.12M
THE CANNABIST COMPANY HOLDINGS INC.	-58.98%	86.63M
4FRONT VENTURES CORP.	-3.85%	83.53M

Medical Farming